國立高雄大學圖資館 |

Multi-factorial approach as a therapeutic strategy for the management of alzheimer's disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Multi-factorial approach as a therapeutic strategy for the management of alzheimer's diseaseedited by Ghulam Md Ashraf ... [et al.].
其他作者:	Ashraf, Ghulam Md.
出版者:	Singapore :Springer Nature Singapore :2024.
面頁冊數:	xviii, 430 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Alzheimer's diseaseTreatment.
電子資源:	https://doi.org/10.1007/978-981-96-0259-9
ISBN:	9789819602599$q(electronic bk.)

Multi-factorial approach as a therapeutic strategy for the management of alzheimer's disease
Multi-factorial approach as a therapeutic strategy for the management of alzheimer's disease[electronic resource] /edited by Ghulam Md Ashraf ... [et al.]. - Singapore :Springer Nature Singapore :2024. - xviii, 430 p. :ill. (some col.), digital ;24 cm.

Part 1. Basic Concepts of neurodegeneration and Alzheimer's disorder -- Basic anatomy and physiology of the central nervous system -- Neurodegenerative disorders: Types, Classification, and basic concepts -- Alzheimer's disorder: epidemiology, etiology, risk factors, future predictions -- Pathophysiology and underlying mechanisms: pathways to Alzheimer's plaque formation -- Correlation of Alzheimer's and other psychologic and non-psychologic conditions -- Part 2. Current scenario of Alzheimer's disorder -- Hurdles & strategies in treating Alzheimer's disorder -- Diagnosis of Alzheimer's, types of plaques and their detection, imaging techniques, and other tests -- Current drugs used: classification, pharmacology -- Approved drug regimens, combinations, and delivery systems for Alzheimer's disorder -- Traditional therapies for Alzheimer's disorder -- Part 3. Novel therapeutic approaches to Alzheimer's Therapy -- Nanotechnology in Alzheimer's -- Targeted drug delivery: amyloid beta targeting drugs, immunotherapy, anti-tau, and aggregation inhibitor, microtubule-stabilizing, and neuro-inflammation modulation -- Neuroprotective approach, microbiome therapy, and overcoming insulin resistance in the brain -- Nonpharmacological approaches: Brain stimulations, vagus nerve stimulation, magnetic and electrical transcranial stimulations -- Part 4. Alzheimer's drug development -- Understanding the potential targets of Alzheimer's disorder -- Upcoming nano and conventional drug delivery strategies for Alzheimer's disorder -- Animal models and ethics in the testing of drugs for Alzheimer's disorder -- Regulatory guidelines and approval process for drugs and formulations for AD -- Part 5. Future of Alzheimer's disorder -- Prevention and reduction of risk of AD: lifestyle changes, dietary changes, supplements, etc -- Natural medicines (phytoconstituents) and probiotics as the future of Alzheimer's Disorder -- Future barriers and possible solutions with recent advances in the field of Alzheimer's disease.

This book is a comprehensive guide to the pathology, underlying mechanisms, and treatment options for Alzheimer's disease (AD). The book starts with an introduction to the basic anatomy and physiology of the central nervous system, followed by an overview of the types, classifications, and basic concepts of neurodegenerative disorders. The epidemiology, etiology, risk factors, and future predictions of AD have been covered in detail. The book then delves into the pathophysiology and underlying mechanisms of plaque formation and explores the correlation of AD with other psychological and non-psychological conditions. The chapters also explore the diagnosis of AD, including types of plaques and their detection, imaging techniques, and other tests. The book also covers traditional therapies for AD and explores the potential application of nanotechnology in AD treatment. The book also covers animal models and ethics in the testing of drugs for AD, regulatory guidelines, and the approval process for drugs and formulations for AD. Prevention and reduction of AD risk are explored, including lifestyle changes, dietary changes, supplements, natural medicines (phytoconstituents), and probiotics as the future of AD. The book concludes with a discussion of future barriers and possible solutions with recent advances in the field of AD. This book is an essential guide for students, researchers, and healthcare professionals interested in Alzheimer's disease research.

ISBN: 9789819602599$q(electronic bk.)

Standard No.: 10.1007/978-981-96-0259-9doiSubjects--Topical Terms:

188756
Alzheimer's disease
--Treatment.

LC Class. No.: RC523

Dewey Class. No.: 616.831106

Multi-factorial approach as a therapeutic strategy for the management of alzheimer's disease
LDR:04534nmm a2200325 a 4500 001 674080
003 DE-He213
005 20250127115243.0
006 m o d
007 cr nn 008maaau
008 250501s2024 si s 0 eng d
020 $a 9789819602599$q(electronic bk.)
020 $a 9789819602582$q(paper)
024 7 $a 10.1007/978-981-96-0259-9 $2 doi
035 $a 978-981-96-0259-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523
072 7 $a PSAN $2 bicssc
072 7 $a SCI089000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 616.831106 $2 23
090 $a RC523 $b .M961 2024
245 0 0 $a Multi-factorial approach as a therapeutic strategy for the management of alzheimer's disease $h [electronic resource] / $c edited by Ghulam Md Ashraf ... [et al.].
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xviii, 430 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part 1. Basic Concepts of neurodegeneration and Alzheimer's disorder -- Basic anatomy and physiology of the central nervous system -- Neurodegenerative disorders: Types, Classification, and basic concepts -- Alzheimer's disorder: epidemiology, etiology, risk factors, future predictions -- Pathophysiology and underlying mechanisms: pathways to Alzheimer's plaque formation -- Correlation of Alzheimer's and other psychologic and non-psychologic conditions -- Part 2. Current scenario of Alzheimer's disorder -- Hurdles & strategies in treating Alzheimer's disorder -- Diagnosis of Alzheimer's, types of plaques and their detection, imaging techniques, and other tests -- Current drugs used: classification, pharmacology -- Approved drug regimens, combinations, and delivery systems for Alzheimer's disorder -- Traditional therapies for Alzheimer's disorder -- Part 3. Novel therapeutic approaches to Alzheimer's Therapy -- Nanotechnology in Alzheimer's -- Targeted drug delivery: amyloid beta targeting drugs, immunotherapy, anti-tau, and aggregation inhibitor, microtubule-stabilizing, and neuro-inflammation modulation -- Neuroprotective approach, microbiome therapy, and overcoming insulin resistance in the brain -- Nonpharmacological approaches: Brain stimulations, vagus nerve stimulation, magnetic and electrical transcranial stimulations -- Part 4. Alzheimer's drug development -- Understanding the potential targets of Alzheimer's disorder -- Upcoming nano and conventional drug delivery strategies for Alzheimer's disorder -- Animal models and ethics in the testing of drugs for Alzheimer's disorder -- Regulatory guidelines and approval process for drugs and formulations for AD -- Part 5. Future of Alzheimer's disorder -- Prevention and reduction of risk of AD: lifestyle changes, dietary changes, supplements, etc -- Natural medicines (phytoconstituents) and probiotics as the future of Alzheimer's Disorder -- Future barriers and possible solutions with recent advances in the field of Alzheimer's disease.
520 $a This book is a comprehensive guide to the pathology, underlying mechanisms, and treatment options for Alzheimer's disease (AD). The book starts with an introduction to the basic anatomy and physiology of the central nervous system, followed by an overview of the types, classifications, and basic concepts of neurodegenerative disorders. The epidemiology, etiology, risk factors, and future predictions of AD have been covered in detail. The book then delves into the pathophysiology and underlying mechanisms of plaque formation and explores the correlation of AD with other psychological and non-psychological conditions. The chapters also explore the diagnosis of AD, including types of plaques and their detection, imaging techniques, and other tests. The book also covers traditional therapies for AD and explores the potential application of nanotechnology in AD treatment. The book also covers animal models and ethics in the testing of drugs for AD, regulatory guidelines, and the approval process for drugs and formulations for AD. Prevention and reduction of AD risk are explored, including lifestyle changes, dietary changes, supplements, natural medicines (phytoconstituents), and probiotics as the future of AD. The book concludes with a discussion of future barriers and possible solutions with recent advances in the field of AD. This book is an essential guide for students, researchers, and healthcare professionals interested in Alzheimer's disease research.
650 0 $a Alzheimer's disease $x Treatment. $3 188756
650 0 $a Neurosciences. $3 211508
650 0 $a Neuropharmacology. $3 275141
650 0 $a Nervous system $x Diseases. $3 209051
650 1 4 $a Neuroscience. $3 297547
650 2 4 $a Neurological Disorders. $3 920956
700 1 $a Ashraf, Ghulam Md. $3 853388
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-96-0259-9
950 $a Medicine (SpringerNature-11650)